Yes — the active ingredient is metabolized by a gene known to vary between individuals.
Relevant genes: BCHE
Anectine is affected by pharmacogenetics through the BCHE gene. Your genotype for this gene can change how your body processes Anectine, which can affect both how well it works and how well you tolerate it. The strongest evidence level on this page is Strong, based on CPIC or FDA guidelines.
Published guidance from FDA on how succinylcholine should be dosed or substituted based on your BCHE phenotype.
| Phenotype | What it means | Recommendation | Evidence |
|---|---|---|---|
|
Intermediate Metabolizer
BCHE
|
Your genetic result suggests you may process this anesthetic more slowly, which could increase the chance of prolonged muscle effects; your doctor may test your sensitivity and adjust the dosing carefully. |
FDA
May administer a test dose to assess sensitivity; if proceeding, administer cautiously via slow infusion with close monitoring.
|
Strong |
|
Poor Metabolizer
BCHE
|
Because your body processes this drug much more slowly, there’s a higher risk of long-lasting muscle effects; your doctor will likely use a different medication. |
FDA
Avoid use of succinylcholine; select alternative agents not affected by BCHE activity.
|
Strong |
|
Normal Metabolizer
BCHE
|
Your genetic result suggests you should process this medicine normally, but your doctor will manage dosing as usual. |
FDA
Initiate therapy with recommended starting dose and adjust per standard clinical practice.
|
Strong |
|
Indeterminate
BCHE
|
The impact of your genotype on response to this drug is unknown. |
FDA
Initiate therapy with recommended starting dose.
|
— |
|
Not available
BCHE
|
The impact of your genotype on response to this drug is unknown. |
FDA
Initiate therapy with recommended starting dose.
|
— |
Source: FDA
This page describes the general pharmacogenetics. A Gene2Rx report analyzes your own DNA to tell you which metabolizer group you fall into, across every medication.
Get your report Look up another medicationInformational only — not medical advice. Pharmacogenetic guidance describes population-level patterns; your individual response depends on many factors. Never start, stop, or change a medication without talking to your prescribing clinician.